WPI 3659 Pill - pink four-sided, 12mm
Pill with imprint WPI 3659 is Pink, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg (base). It is supplied by Actavis Pharma, Inc.
Desvenlafaxine is used in the treatment of Major Depressive Disorder; Depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3659
Desvenlafaxine Succinate Extended-Release
- Imprint
- WPI 3659
- Strength
- 50 mg (base)
- Color
- Pink
- Size
- 12.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3659
- Inactive Ingredients
-
hypromelloses,
microcrystalline cellulose,
magnesium silicate,
magnesium stearate,
silicon dioxide,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
propylene glycol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
See also:
More about desvenlafaxine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,390)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: serotonin-norepinephrine reuptake inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.